drugset / Trial / NCT00415194
A Study for Patients With Head and Neck Cancer
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will compare the effects of pemetrexed plus cisplatin versus cisplatin alone in head and neck cancer patients.
Timeline
- Start
- 2006-12
- Primary completion
- 2010-03
- Completion
- 2010-03
Outcome
Missed primary endpoint
registry Pemetrexed/Cisplatin vs Placebo/Cisplatin; p = 0.082 NCT00415194 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pemetrexed | Small molecule | 500 mg/m2 | Intravenous |
| Background | Cisplatin | Other / unclassified | 75 mg/m2 | Intravenous |